nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—CYP1A2—chronic obstructive pulmonary disease	0.253	0.634	CbGaD
Fluorouracil—ALB—chronic obstructive pulmonary disease	0.146	0.366	CbGaD
Fluorouracil—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0737	0.195	CbGbCtD
Fluorouracil—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0737	0.195	CbGbCtD
Fluorouracil—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0559	0.148	CbGbCtD
Fluorouracil—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0328	0.0869	CbGbCtD
Fluorouracil—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0275	0.073	CbGbCtD
Fluorouracil—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0253	0.0672	CbGbCtD
Fluorouracil—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0253	0.0672	CbGbCtD
Fluorouracil—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0239	0.0634	CbGbCtD
Fluorouracil—ALB—Prednisone—chronic obstructive pulmonary disease	0.0197	0.0524	CbGbCtD
Fluorouracil—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0192	0.0509	CbGbCtD
Fluorouracil—UPP1—respiratory system—chronic obstructive pulmonary disease	0.00337	0.0695	CbGeAlD
Fluorouracil—UMPS—bronchus—chronic obstructive pulmonary disease	0.00303	0.0624	CbGeAlD
Fluorouracil—UPP1—bronchus—chronic obstructive pulmonary disease	0.00278	0.0572	CbGeAlD
Fluorouracil—UPP1—trachea—chronic obstructive pulmonary disease	0.00249	0.0514	CbGeAlD
Fluorouracil—DPYD—bronchus—chronic obstructive pulmonary disease	0.00225	0.0465	CbGeAlD
Fluorouracil—UMPS—lung—chronic obstructive pulmonary disease	0.00195	0.0403	CbGeAlD
Fluorouracil—UPP1—lung—chronic obstructive pulmonary disease	0.00179	0.0369	CbGeAlD
Fluorouracil—TYMP—respiratory system—chronic obstructive pulmonary disease	0.00159	0.0327	CbGeAlD
Fluorouracil—MTHFR—respiratory system—chronic obstructive pulmonary disease	0.00149	0.0307	CbGeAlD
Fluorouracil—DPYD—lung—chronic obstructive pulmonary disease	0.00145	0.03	CbGeAlD
Fluorouracil—TYMP—connective tissue—chronic obstructive pulmonary disease	0.0014	0.0288	CbGeAlD
Fluorouracil—TYMS—respiratory system—chronic obstructive pulmonary disease	0.00136	0.0281	CbGeAlD
Fluorouracil—TYMP—bronchus—chronic obstructive pulmonary disease	0.00131	0.0269	CbGeAlD
Fluorouracil—TYMP—smooth muscle tissue—chronic obstructive pulmonary disease	0.00128	0.0263	CbGeAlD
Fluorouracil—PPAT—lung—chronic obstructive pulmonary disease	0.00126	0.0259	CbGeAlD
Fluorouracil—MTHFR—bronchus—chronic obstructive pulmonary disease	0.00123	0.0253	CbGeAlD
Fluorouracil—SLC29A1—respiratory system—chronic obstructive pulmonary disease	0.00122	0.0252	CbGeAlD
Fluorouracil—TYMS—connective tissue—chronic obstructive pulmonary disease	0.0012	0.0247	CbGeAlD
Fluorouracil—TYMP—trachea—chronic obstructive pulmonary disease	0.00117	0.0242	CbGeAlD
Fluorouracil—TYMS—bronchus—chronic obstructive pulmonary disease	0.00112	0.0231	CbGeAlD
Fluorouracil—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.00112	0.023	CbGeAlD
Fluorouracil—TYMS—smooth muscle tissue—chronic obstructive pulmonary disease	0.0011	0.0226	CbGeAlD
Fluorouracil—ABCC5—bronchus—chronic obstructive pulmonary disease	0.00109	0.0226	CbGeAlD
Fluorouracil—SLC29A1—connective tissue—chronic obstructive pulmonary disease	0.00108	0.0221	CbGeAlD
Fluorouracil—SLC29A1—bronchus—chronic obstructive pulmonary disease	0.00101	0.0207	CbGeAlD
Fluorouracil—SLC29A1—trachea—chronic obstructive pulmonary disease	0.000903	0.0186	CbGeAlD
Fluorouracil—TYMP—lung—chronic obstructive pulmonary disease	0.000843	0.0174	CbGeAlD
Fluorouracil—MTHFR—lung—chronic obstructive pulmonary disease	0.000792	0.0163	CbGeAlD
Fluorouracil—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000759	0.0156	CbGeAlD
Fluorouracil—TYMS—lung—chronic obstructive pulmonary disease	0.000723	0.0149	CbGeAlD
Fluorouracil—ABCC5—lung—chronic obstructive pulmonary disease	0.000706	0.0146	CbGeAlD
Fluorouracil—SLC29A1—lung—chronic obstructive pulmonary disease	0.000649	0.0134	CbGeAlD
Fluorouracil—CYP2A6—lung—chronic obstructive pulmonary disease	0.000633	0.013	CbGeAlD
Fluorouracil—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000626	0.0129	CbGeAlD
Fluorouracil—ABCC3—lung—chronic obstructive pulmonary disease	0.000593	0.0122	CbGeAlD
Fluorouracil—ABCC4—lung—chronic obstructive pulmonary disease	0.00049	0.0101	CbGeAlD
Fluorouracil—ABCG2—lung—chronic obstructive pulmonary disease	0.000346	0.00712	CbGeAlD
Fluorouracil—CYP1A2—lung—chronic obstructive pulmonary disease	0.000333	0.00685	CbGeAlD
Fluorouracil—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000327	0.003	CcSEcCtD
Fluorouracil—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00297	CcSEcCtD
Fluorouracil—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00297	CcSEcCtD
Fluorouracil—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00296	CcSEcCtD
Fluorouracil—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00294	CcSEcCtD
Fluorouracil—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00294	CcSEcCtD
Fluorouracil—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000319	0.00292	CcSEcCtD
Fluorouracil—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000317	0.00291	CcSEcCtD
Fluorouracil—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000316	0.0029	CcSEcCtD
Fluorouracil—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000316	0.0029	CcSEcCtD
Fluorouracil—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00288	CcSEcCtD
Fluorouracil—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00288	CcSEcCtD
Fluorouracil—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.00287	CcSEcCtD
Fluorouracil—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.00285	CcSEcCtD
Fluorouracil—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000309	0.00283	CcSEcCtD
Fluorouracil—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.0028	CcSEcCtD
Fluorouracil—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000305	0.0028	CcSEcCtD
Fluorouracil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000304	0.00279	CcSEcCtD
Fluorouracil—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000304	0.00279	CcSEcCtD
Fluorouracil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000301	0.00276	CcSEcCtD
Fluorouracil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000301	0.00276	CcSEcCtD
Fluorouracil—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000301	0.00276	CcSEcCtD
Fluorouracil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0003	0.00275	CcSEcCtD
Fluorouracil—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000299	0.00274	CcSEcCtD
Fluorouracil—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.00273	CcSEcCtD
Fluorouracil—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.0027	CcSEcCtD
Fluorouracil—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00269	CcSEcCtD
Fluorouracil—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.00264	CcSEcCtD
Fluorouracil—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00264	CcSEcCtD
Fluorouracil—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00261	CcSEcCtD
Fluorouracil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000284	0.0026	CcSEcCtD
Fluorouracil—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000283	0.0026	CcSEcCtD
Fluorouracil—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000281	0.00257	CcSEcCtD
Fluorouracil—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00257	CcSEcCtD
Fluorouracil—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.00254	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.00251	CcSEcCtD
Fluorouracil—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.00249	CcSEcCtD
Fluorouracil—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00248	CcSEcCtD
Fluorouracil—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.00245	CcSEcCtD
Fluorouracil—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00243	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00238	CcSEcCtD
Fluorouracil—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.00233	CcSEcCtD
Fluorouracil—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000253	0.00232	CcSEcCtD
Fluorouracil—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00232	CcSEcCtD
Fluorouracil—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00232	CcSEcCtD
Fluorouracil—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00232	CcSEcCtD
Fluorouracil—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00232	CcSEcCtD
Fluorouracil—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00231	CcSEcCtD
Fluorouracil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000252	0.00231	CcSEcCtD
Fluorouracil—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00229	CcSEcCtD
Fluorouracil—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00229	CcSEcCtD
Fluorouracil—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00227	CcSEcCtD
Fluorouracil—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.00225	CcSEcCtD
Fluorouracil—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00224	CcSEcCtD
Fluorouracil—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00223	CcSEcCtD
Fluorouracil—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00223	CcSEcCtD
Fluorouracil—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00223	CcSEcCtD
Fluorouracil—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00223	CcSEcCtD
Fluorouracil—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00221	CcSEcCtD
Fluorouracil—Infection—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00221	CcSEcCtD
Fluorouracil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00219	CcSEcCtD
Fluorouracil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00219	CcSEcCtD
Fluorouracil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000239	0.00219	CcSEcCtD
Fluorouracil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00218	CcSEcCtD
Fluorouracil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00218	CcSEcCtD
Fluorouracil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00218	CcSEcCtD
Fluorouracil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00218	CcSEcCtD
Fluorouracil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00217	CcSEcCtD
Fluorouracil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00217	CcSEcCtD
Fluorouracil—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00217	CcSEcCtD
Fluorouracil—Infection—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00217	CcSEcCtD
Fluorouracil—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00216	CcSEcCtD
Fluorouracil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.00215	CcSEcCtD
Fluorouracil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00214	CcSEcCtD
Fluorouracil—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00213	CcSEcCtD
Fluorouracil—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00213	CcSEcCtD
Fluorouracil—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00023	0.00211	CcSEcCtD
Fluorouracil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.0021	CcSEcCtD
Fluorouracil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.0021	CcSEcCtD
Fluorouracil—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00209	CcSEcCtD
Fluorouracil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00208	CcSEcCtD
Fluorouracil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00208	CcSEcCtD
Fluorouracil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000226	0.00207	CcSEcCtD
Fluorouracil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00206	CcSEcCtD
Fluorouracil—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000224	0.00206	CcSEcCtD
Fluorouracil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00205	CcSEcCtD
Fluorouracil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.00203	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00203	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00203	CcSEcCtD
Fluorouracil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00201	CcSEcCtD
Fluorouracil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00201	CcSEcCtD
Fluorouracil—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.002	CcSEcCtD
Fluorouracil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000218	0.002	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00199	CcSEcCtD
Fluorouracil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00198	CcSEcCtD
Fluorouracil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00198	CcSEcCtD
Fluorouracil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00198	CcSEcCtD
Fluorouracil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00198	CcSEcCtD
Fluorouracil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00197	CcSEcCtD
Fluorouracil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00196	CcSEcCtD
Fluorouracil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00196	CcSEcCtD
Fluorouracil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00196	CcSEcCtD
Fluorouracil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00196	CcSEcCtD
Fluorouracil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.00195	CcSEcCtD
Fluorouracil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00194	CcSEcCtD
Fluorouracil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000211	0.00193	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00192	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00192	CcSEcCtD
Fluorouracil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00192	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00191	CcSEcCtD
Fluorouracil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000208	0.0019	CcSEcCtD
Fluorouracil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.0019	CcSEcCtD
Fluorouracil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.0019	CcSEcCtD
Fluorouracil—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000207	0.0019	CcSEcCtD
Fluorouracil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00189	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00188	CcSEcCtD
Fluorouracil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00187	CcSEcCtD
Fluorouracil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00187	CcSEcCtD
Fluorouracil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00186	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00186	CcSEcCtD
Fluorouracil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.00186	CcSEcCtD
Fluorouracil—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.00185	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.00185	CcSEcCtD
Fluorouracil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00185	CcSEcCtD
Fluorouracil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000201	0.00184	CcSEcCtD
Fluorouracil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000201	0.00184	CcSEcCtD
Fluorouracil—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00184	CcSEcCtD
Fluorouracil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00183	CcSEcCtD
Fluorouracil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00183	CcSEcCtD
Fluorouracil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0002	0.00183	CcSEcCtD
Fluorouracil—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00183	CcSEcCtD
Fluorouracil—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00183	CcSEcCtD
Fluorouracil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00182	CcSEcCtD
Fluorouracil—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00182	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00181	CcSEcCtD
Fluorouracil—TYMS—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.000196	0.1	CbGdCrCtD
Fluorouracil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.0018	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00178	CcSEcCtD
Fluorouracil—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00178	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.000194	0.0992	CbGdCrCtD
Fluorouracil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00177	CcSEcCtD
Fluorouracil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00177	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.000192	0.0982	CbGdCrCtD
Fluorouracil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00176	CcSEcCtD
Fluorouracil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00176	CcSEcCtD
Fluorouracil—TYMS—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.0981	CbGdCrCtD
Fluorouracil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.00175	CcSEcCtD
Fluorouracil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.00174	CcSEcCtD
Fluorouracil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000189	0.00174	CcSEcCtD
Fluorouracil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000189	0.00174	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.0968	CbGdCrCtD
Fluorouracil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00173	CcSEcCtD
Fluorouracil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00173	CcSEcCtD
Fluorouracil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000188	0.00173	CcSEcCtD
Fluorouracil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00172	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.0958	CbGdCrCtD
Fluorouracil—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00171	CcSEcCtD
Fluorouracil—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000185	0.0017	CcSEcCtD
Fluorouracil—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.0017	CcSEcCtD
Fluorouracil—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00169	CcSEcCtD
Fluorouracil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00167	CcSEcCtD
Fluorouracil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00166	CcSEcCtD
Fluorouracil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00164	CcSEcCtD
Fluorouracil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00164	CcSEcCtD
Fluorouracil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.00164	CcSEcCtD
Fluorouracil—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00163	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.000177	0.0905	CbGdCrCtD
Fluorouracil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00161	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.0883	CbGdCrCtD
Fluorouracil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00157	CcSEcCtD
Fluorouracil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00157	CcSEcCtD
Fluorouracil—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00157	CcSEcCtD
Fluorouracil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00155	CcSEcCtD
Fluorouracil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00154	CcSEcCtD
Fluorouracil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00152	CcSEcCtD
Fluorouracil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00152	CcSEcCtD
Fluorouracil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00152	CcSEcCtD
Fluorouracil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00149	CcSEcCtD
Fluorouracil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00149	CcSEcCtD
Fluorouracil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00148	CcSEcCtD
Fluorouracil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00147	CcSEcCtD
Fluorouracil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00147	CcSEcCtD
Fluorouracil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00144	CcSEcCtD
Fluorouracil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00144	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.000155	0.0793	CbGdCrCtD
Fluorouracil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00142	CcSEcCtD
Fluorouracil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00142	CcSEcCtD
Fluorouracil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000153	0.0014	CcSEcCtD
Fluorouracil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.0014	CcSEcCtD
Fluorouracil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.0014	CcSEcCtD
Fluorouracil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000153	0.0014	CcSEcCtD
Fluorouracil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00139	CcSEcCtD
Fluorouracil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00139	CcSEcCtD
Fluorouracil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00139	CcSEcCtD
Fluorouracil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00139	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.0774	CbGdCrCtD
Fluorouracil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00139	CcSEcCtD
Fluorouracil—Rash—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00137	CcSEcCtD
Fluorouracil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00137	CcSEcCtD
Fluorouracil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00137	CcSEcCtD
Fluorouracil—TYMS—Danazol—Prednisone—chronic obstructive pulmonary disease	0.000149	0.076	CbGdCrCtD
Fluorouracil—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00135	CcSEcCtD
Fluorouracil—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00135	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00135	CcSEcCtD
Fluorouracil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00134	CcSEcCtD
Fluorouracil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00133	CcSEcCtD
Fluorouracil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00132	CcSEcCtD
Fluorouracil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00132	CcSEcCtD
Fluorouracil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00132	CcSEcCtD
Fluorouracil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00132	CcSEcCtD
Fluorouracil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000141	0.00129	CcSEcCtD
Fluorouracil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00128	CcSEcCtD
Fluorouracil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00125	CcSEcCtD
Fluorouracil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00124	CcSEcCtD
Fluorouracil—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00124	CcSEcCtD
Fluorouracil—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00123	CcSEcCtD
Fluorouracil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00121	CcSEcCtD
Fluorouracil—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00121	CcSEcCtD
Fluorouracil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00118	CcSEcCtD
Fluorouracil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.0011	CcSEcCtD
Fluorouracil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00109	CcSEcCtD
Fluorouracil—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00109	CcSEcCtD
Fluorouracil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00108	CcSEcCtD
Fluorouracil—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00107	CcSEcCtD
Fluorouracil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00103	CcSEcCtD
Fluorouracil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00101	CcSEcCtD
Fluorouracil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000993	CcSEcCtD
Fluorouracil—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000992	CcSEcCtD
Fluorouracil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000958	CcSEcCtD
Fluorouracil—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00093	CcSEcCtD
Fluorouracil—Myalgia—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000914	CcSEcCtD
Fluorouracil—Discomfort—Prednisone—chronic obstructive pulmonary disease	9.84e-05	0.000903	CcSEcCtD
Fluorouracil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	9.68e-05	0.000888	CcSEcCtD
Fluorouracil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	9.55e-05	0.000876	CcSEcCtD
Fluorouracil—Oedema—Prednisone—chronic obstructive pulmonary disease	9.55e-05	0.000876	CcSEcCtD
Fluorouracil—Infection—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.00087	CcSEcCtD
Fluorouracil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000859	CcSEcCtD
Fluorouracil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.32e-05	0.000855	CcSEcCtD
Fluorouracil—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000835	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.000798	CcSEcCtD
Fluorouracil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.69e-05	0.000797	CcSEcCtD
Fluorouracil—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000792	CcSEcCtD
Fluorouracil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.58e-05	0.000787	CcSEcCtD
Fluorouracil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000771	CcSEcCtD
Fluorouracil—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.000761	CcSEcCtD
Fluorouracil—Rash—Prednisolone—chronic obstructive pulmonary disease	8.29e-05	0.00076	CcSEcCtD
Fluorouracil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.28e-05	0.000759	CcSEcCtD
Fluorouracil—Headache—Prednisolone—chronic obstructive pulmonary disease	8.23e-05	0.000755	CcSEcCtD
Fluorouracil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.87e-05	0.000722	CcSEcCtD
Fluorouracil—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.81e-05	0.000716	CcSEcCtD
Fluorouracil—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.000696	CcSEcCtD
Fluorouracil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.55e-05	0.000692	CcSEcCtD
Fluorouracil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.04e-05	0.000645	CcSEcCtD
Fluorouracil—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.00062	CcSEcCtD
Fluorouracil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000599	CcSEcCtD
Fluorouracil—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000579	CcSEcCtD
Fluorouracil—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000557	CcSEcCtD
Fluorouracil—Rash—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000552	CcSEcCtD
Fluorouracil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000552	CcSEcCtD
Fluorouracil—Headache—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000549	CcSEcCtD
Fluorouracil—Nausea—Prednisone—chronic obstructive pulmonary disease	5.67e-05	0.00052	CcSEcCtD
Fluorouracil—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.28e-05	0.000661	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.26e-05	0.000658	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.26e-05	0.000658	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.24e-05	0.000654	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.22e-05	0.000652	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.18e-05	0.000645	CbGpPWpGaD
Fluorouracil—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.18e-05	0.000645	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.14e-05	0.000639	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.1e-05	0.000633	CbGpPWpGaD
Fluorouracil—ABCC4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.07e-05	0.000629	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.04e-05	0.000624	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	3.99e-05	0.000616	CbGpPWpGaD
Fluorouracil—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.99e-05	0.000616	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.94e-05	0.000609	CbGpPWpGaD
Fluorouracil—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.94e-05	0.000607	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HDAC2—chronic obstructive pulmonary disease	3.91e-05	0.000604	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.9e-05	0.000602	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GCLC—chronic obstructive pulmonary disease	3.86e-05	0.000595	CbGpPWpGaD
Fluorouracil—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.78e-05	0.000584	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.77e-05	0.000581	CbGpPWpGaD
Fluorouracil—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.73e-05	0.000576	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.65e-05	0.000564	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KL—chronic obstructive pulmonary disease	3.64e-05	0.000562	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.58e-05	0.000553	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.57e-05	0.000551	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	3.56e-05	0.000549	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.54e-05	0.000546	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.53e-05	0.000545	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CTGF—chronic obstructive pulmonary disease	3.52e-05	0.000543	CbGpPWpGaD
Fluorouracil—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.49e-05	0.000538	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.48e-05	0.000536	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.44e-05	0.00053	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HDAC2—chronic obstructive pulmonary disease	3.41e-05	0.000526	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—ALB—chronic obstructive pulmonary disease	3.41e-05	0.000526	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—ALB—chronic obstructive pulmonary disease	3.41e-05	0.000526	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.4e-05	0.000524	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.39e-05	0.000524	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.36e-05	0.000518	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.34e-05	0.000515	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—NOS3—chronic obstructive pulmonary disease	3.26e-05	0.000503	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—NOS3—chronic obstructive pulmonary disease	3.26e-05	0.000503	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.25e-05	0.000502	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.25e-05	0.000501	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.25e-05	0.000501	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.25e-05	0.000501	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.25e-05	0.000501	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.24e-05	0.0005	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.22e-05	0.000497	CbGpPWpGaD
Fluorouracil—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.2e-05	0.000494	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.19e-05	0.000492	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.19e-05	0.000492	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.19e-05	0.000492	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KL—chronic obstructive pulmonary disease	3.17e-05	0.000489	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	3.16e-05	0.000488	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.14e-05	0.000485	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.1e-05	0.000478	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.09e-05	0.000476	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.08e-05	0.000475	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.06e-05	0.000473	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.06e-05	0.000473	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.05e-05	0.000471	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.04e-05	0.00047	CbGpPWpGaD
Fluorouracil—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.000469	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.03e-05	0.000468	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.03e-05	0.000468	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.03e-05	0.000467	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.02e-05	0.000467	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.02e-05	0.000466	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GCLC—chronic obstructive pulmonary disease	2.99e-05	0.000461	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	2.98e-05	0.00046	CbGpPWpGaD
Fluorouracil—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.98e-05	0.00046	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.98e-05	0.000459	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.95e-05	0.000455	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.94e-05	0.000453	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.92e-05	0.000451	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	2.87e-05	0.000443	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	2.86e-05	0.000442	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	2.84e-05	0.000439	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	2.84e-05	0.000438	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.84e-05	0.000438	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.82e-05	0.000436	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.78e-05	0.000428	CbGpPWpGaD
Fluorouracil—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.74e-05	0.000422	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CTGF—chronic obstructive pulmonary disease	2.73e-05	0.000421	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ERBB3—chronic obstructive pulmonary disease	2.73e-05	0.000421	CbGpPWpGaD
Fluorouracil—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.71e-05	0.000419	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.7e-05	0.000417	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.67e-05	0.000412	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.67e-05	0.000412	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.63e-05	0.000406	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.62e-05	0.000405	CbGpPWpGaD
Fluorouracil—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.0004	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.58e-05	0.000398	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.56e-05	0.000395	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.52e-05	0.000389	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.51e-05	0.000388	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.5e-05	0.000386	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.48e-05	0.000383	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.48e-05	0.000382	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.47e-05	0.000382	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.46e-05	0.00038	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ALB—chronic obstructive pulmonary disease	2.43e-05	0.000375	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.39e-05	0.000368	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	2.38e-05	0.000368	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ERBB3—chronic obstructive pulmonary disease	2.38e-05	0.000367	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.36e-05	0.000364	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.35e-05	0.000363	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—NOS3—chronic obstructive pulmonary disease	2.32e-05	0.000358	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.32e-05	0.000358	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.31e-05	0.000356	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.28e-05	0.000352	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NOS2—chronic obstructive pulmonary disease	2.27e-05	0.000351	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.26e-05	0.000349	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.21e-05	0.000341	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.19e-05	0.000339	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.17e-05	0.000335	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.16e-05	0.000334	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.16e-05	0.000333	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.12e-05	0.000327	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.1e-05	0.000324	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.1e-05	0.000323	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.08e-05	0.000321	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.08e-05	0.000321	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.07e-05	0.000319	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.06e-05	0.000318	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.05e-05	0.000316	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.02e-05	0.000311	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2e-05	0.000309	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2e-05	0.000309	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.99e-05	0.000307	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.99e-05	0.000307	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NOS2—chronic obstructive pulmonary disease	1.98e-05	0.000306	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.96e-05	0.000303	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GC—chronic obstructive pulmonary disease	1.95e-05	0.000301	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.93e-05	0.000297	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SERPINE1—chronic obstructive pulmonary disease	1.92e-05	0.000296	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NOS3—chronic obstructive pulmonary disease	1.83e-05	0.000282	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.83e-05	0.000282	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.82e-05	0.000281	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.81e-05	0.00028	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.77e-05	0.000273	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.74e-05	0.000268	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.73e-05	0.000266	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.71e-05	0.000264	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.71e-05	0.000263	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SERPINE1—chronic obstructive pulmonary disease	1.67e-05	0.000257	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.64e-05	0.000253	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.64e-05	0.000253	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.63e-05	0.000251	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ALB—chronic obstructive pulmonary disease	1.6e-05	0.000247	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.6e-05	0.000246	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.59e-05	0.000246	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NOS3—chronic obstructive pulmonary disease	1.59e-05	0.000246	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.57e-05	0.000242	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.00024	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.55e-05	0.00024	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.55e-05	0.000239	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—NOS3—chronic obstructive pulmonary disease	1.53e-05	0.000236	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.51e-05	0.000233	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.51e-05	0.000233	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.51e-05	0.000233	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.51e-05	0.000233	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.5e-05	0.000232	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.48e-05	0.000229	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.45e-05	0.000224	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000223	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.44e-05	0.000222	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000221	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.42e-05	0.00022	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.41e-05	0.000218	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.4e-05	0.000216	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.4e-05	0.000216	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000215	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.36e-05	0.00021	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.33e-05	0.000206	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.32e-05	0.000204	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.3e-05	0.000201	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.28e-05	0.000198	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.27e-05	0.000196	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000192	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.24e-05	0.000191	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TGFB1—chronic obstructive pulmonary disease	1.21e-05	0.000187	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.000185	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.000183	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EGFR—chronic obstructive pulmonary disease	1.19e-05	0.000183	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.18e-05	0.000182	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000182	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.00017	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.09e-05	0.000168	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.08e-05	0.000167	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	0.000165	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.07e-05	0.000165	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.07e-05	0.000164	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.06e-05	0.000163	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.000162	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—chronic obstructive pulmonary disease	1.05e-05	0.000162	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000161	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGFR—chronic obstructive pulmonary disease	1.03e-05	0.000159	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.03e-05	0.000159	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-05	0.000159	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.000156	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.99e-06	0.000154	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.87e-06	0.000152	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	9.83e-06	0.000152	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	9.66e-06	0.000149	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	9.61e-06	0.000148	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.47e-06	0.000146	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—chronic obstructive pulmonary disease	9.11e-06	0.000141	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.9e-06	0.000137	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.85e-06	0.000137	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.72e-06	0.000135	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	8.62e-06	0.000133	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.04e-06	0.000124	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—chronic obstructive pulmonary disease	7.93e-06	0.000122	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.86e-06	0.000121	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.45e-06	0.000115	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.43e-06	0.000115	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.43e-06	0.000115	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.38e-06	0.000114	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.36e-06	0.000114	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.32e-06	0.000113	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.28e-06	0.000112	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.25e-06	0.000112	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	7.09e-06	0.000109	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.87e-06	0.000106	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.82e-06	0.000105	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	6.82e-06	0.000105	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.78e-06	0.000105	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.78e-06	0.000105	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.72e-06	0.000104	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.47e-06	9.98e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	6.44e-06	9.93e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.43e-06	9.93e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.16e-06	9.5e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.04e-06	9.33e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.96e-06	9.2e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	5.62e-06	8.67e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.55e-06	8.57e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.26e-06	8.12e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.16e-06	7.97e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.09e-06	7.86e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.75e-06	7.32e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.5e-06	6.94e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.4e-06	6.79e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.21e-06	6.49e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.18e-06	6.45e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.58e-06	5.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.42e-06	5.28e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.06e-06	4.72e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.93e-06	4.51e-05	CbGpPWpGaD
